Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma

BACKGROUND: Although sorafenib is accepted as the standard of care in advanced hepatocellular carcinoma (HCC), its therapeutic benefit is marginal. Here, we aimed to compare the efficacy and safety of sorafenib monotherapy (S-M) and sorafenib-based loco-regional treatments (S-LRTs) in advanced HCC....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lee, Sangheun, Kim, Beom Kyung, Kim, Seung Up, Park, Yehyun, Chang, Sooyun, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Chon, Chae Yoon, Han, Kwang-Hyub
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3796498/
https://ncbi.nlm.nih.gov/pubmed/24155932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0077240
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars